Drug Shortage Report for TEVA-ROSUVASTATIN
| Report ID | 120318 |
| Drug Identification Number | 02354608 |
| Brand name | TEVA-ROSUVASTATIN |
| Common or Proper name | ROSUVASTATIN 5MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ROSUVASTATIN |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | p pack 30's |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2020-07-14 |
| Estimated end date | 2021-06-30 |
| Actual end date | 2021-07-08 |
| Shortage status | Resolved |
| Updated date | 2021-07-09 |
| Company comments | Allocating to 100% of Teva market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.